Global health funders back iKure with $1.8M to scale rural primary care in India
What's the deal? iKure TechsoftDealroom has a profile for this one. Try Dealroom → has raised $1.8 million in a round backed by four global healthcare, foundation, and strategic investors. Philips FoundationDealroom has a profile for this one. Try Dealroom →, World Diabetes FoundationDealroom has a profile for this one. Try Dealroom →, Bayer FoundationDealroom has a profile for this one. Try Dealroom → (via We Share Forward), and Japan's Prourgn LLC each committed independently after evaluating the company's model, platform, and ability to scale.
What does iKure do? The company delivers technology-enabled primary healthcare across 11 Indian states, reaching 7,900 villages and more than 36 million people. It runs healthcare hubs, clinics, pharmacies, diagnostics, and telemedicine, unified through its proprietary platform, WHIMS, and delivered by over 400 trained Community Health Activists.
Why now? India has widened access to health screening, but keeping patients in care after the first visit remains the harder problem. Diabetes, hypertension, and maternal health complications need ongoing monitoring, and non-communicable disease is now the leading cause of death in the country.
What's the money for? iKure plans to add health workers and expand its hubs, clinics, pharmacies, and diagnostics across underserved regions. A significant share goes into WHIMS, including new AI-enabled clinical decision support to flag patient risk earlier and help clinical teams manage larger populations.
What's the endgame? The model ties field workers to patient records that carry forward between visits, so a diagnosis at a hub becomes a case a health worker follows up on weeks later. Diabetes360, its chronic disease program, routes ongoing care through the same field network used for maternal health and cardiac monitoring. More than 10,000 women-led self-help groups extend that reach into households.
The signal: Four investors with different mandates arriving independently at the same company points to growing confidence in scalable, technology-enabled primary care built in India — models designed to close the gap between diagnosis and follow-up.
Read more: businessmicro.in
Image credit: Generated with Gemini
